Marc Nash - 17 Jul 2023 Form 3 Insider Report for Outset Medical, Inc. (OM)

Role
SVP, Operations and R&D
Signature
/s/ By: John L. Brottem For: Marc Nash
Issuer symbol
OM
Transactions as of
17 Jul 2023
Net transactions value
$0
Form type
3
Filing time
24 Jul 2023, 17:29:05 UTC
Next filing
24 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OM Common Stock 39,195 17 Jul 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OM Non-Qualified Stock Option (right to buy) 17 Jul 2023 Common Stock 18,987 $8.62 Direct F1
holding OM Non-Qualified Stock Option (right to buy) 17 Jul 2023 Common Stock 7,207 $46.94 Direct F1
holding OM Non-Qualified Stock Option (right to buy) 17 Jul 2023 Common Stock 1,738 $50.01 Direct F1
holding OM Performance Options (right to buy) 17 Jul 2023 Common Stock 12,658 $8.62 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the option shall vest on the first anniversary of the grant date and thereafter, 1/48th of such total number of shares shall vest on each monthly anniversary of the grant date, subject to the reporting person's continuous service through the applicable vesting date.
F2 In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney